Biomimetic Ghost Nanomedicine-Based Optotheranostics for Cancer

Area of Science:

• Theranostic medicine
• Nanomedicine
• Biotechnology

Background:

• Theranostic medicine integrates diagnostics and therapeutics, particularly for solid tumors, using minimal drug doses.
• Optically activated photosensitizers are key components in optotheranostics, converting light into imaging signals, therapeutic radicals, and heat.
• Current photosensitizers require protection and targeted delivery, posing challenges for clinical application.

Purpose of the Study:

• To review the role of biomimetic nanoparticles in light-mediated tumor diagnosis and therapy.
• To explore the preclinical and clinical status of these advanced theranostic systems.
• To highlight the advantages of cell membrane biomimetic ghosts for delivering photosensitizers.

Main Methods:

• Review of existing literature on optotheranostics and biomimetic nanoparticle applications.
• Analysis of photosensitizer properties and their interaction with light for therapeutic and diagnostic purposes.
• Evaluation of cell membrane biomimetic ghosts as delivery vehicles for photosensitizers.

Main Results:

• Biomimetic nanoparticles, utilizing cell membrane ghosts, provide biocompatibility, prolonged circulation, immune evasion, and targeted delivery.
• These nanoparticles protect optically active molecules, enabling site-specific delivery crucial for effective treatment.
• Optotheranostics utilizing these systems demonstrate potential in killing tumor cells via reactive oxygen species, heat, or antigen release.

Conclusions:

• Cell membrane biomimetic ghosts represent a promising strategy for the precise and safe delivery of photosensitizers in theranostic medicine.
• Biomimetic nanoparticles enhance the clinical relevance of optotheranostics for solid tumor treatment and diagnosis.
• Further investigation into their preclinical and clinical status is warranted to fully realize their therapeutic potential.